Solid Biosciences (SLDB) News Today $4.51 -0.07 (-1.53%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$4.48 -0.03 (-0.67%) As of 06/13/2025 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SLDB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Solid Biosciences Approves Equity Plan Amendment at MeetingJune 13 at 5:13 PM | tipranks.comAnalysts Offer Predictions for SLDB FY2026 EarningsJune 11, 2025 | americanbankingnews.comBrokers Offer Predictions for SLDB FY2026 EarningsSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for Solid Biosciences in a note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska expects that the company will post earninJune 10, 2025 | marketbeat.comSolid Biosciences Inc. (NASDAQ:SLDB) Shares Sold by Two Sigma Investments LPTwo Sigma Investments LP cut its stake in Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 32.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 136,145 shares of the company's stock after selling 66,817 shares durJune 9, 2025 | marketbeat.comSolid Biosciences' (SLDB) Market Outperform Rating Reaffirmed at JMP SecuritiesJune 8, 2025 | americanbankingnews.comSolid Biosciences' (SLDB) "Market Outperform" Rating Reiterated at JMP SecuritiesJMP Securities reissued a "market outperform" rating and issued a $15.00 target price on shares of Solid Biosciences in a research report on Friday.June 6, 2025 | marketbeat.comShort Interest in Solid Biosciences Inc. (NASDAQ:SLDB) Increases By 27.6%June 5, 2025 | americanbankingnews.comSolid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 3, 2025 | globenewswire.comSolid Biosciences Inc. (NASDAQ:SLDB) Short Interest UpdateSolid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) was the recipient of a large growth in short interest in May. As of May 15th, there was short interest totalling 9,050,000 shares, a growth of 27.6% from the April 30th total of 7,090,000 shares. Based on an average daily volume of 1,480,000 shares, the short-interest ratio is currently 6.1 days. Currently, 16.0% of the shares of the stock are short sold.June 3, 2025 | marketbeat.comMillennium Management LLC Sells 397,321 Shares of Solid Biosciences Inc. (NASDAQ:SLDB)Millennium Management LLC trimmed its position in Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 35.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 719,776 shares of the company's sJune 1, 2025 | marketbeat.comSolid Biosciences’ SWOT analysis: gene therapy stock poised for potential breakthroughMay 28, 2025 | investing.comSolid Biosciences to Participate at the Jefferies Global Healthcare ConferenceMay 28, 2025 | globenewswire.comSolid Biosciences Inc. (NASDAQ:SLDB) Given Consensus Recommendation of "Buy" by BrokeragesShares of Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) have been assigned a consensus recommendation of "Buy" from the thirteen ratings firms that are currently covering the company, Marketbeat.com reports. Ten research analysts have rated the stock with a buy rating and three have assignMay 28, 2025 | marketbeat.comResearch Analysts Set Expectations for SLDB FY2025 EarningsSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Equities researchers at Cantor Fitzgerald dropped their FY2025 EPS estimates for Solid Biosciences in a note issued to investors on Thursday, May 22nd. Cantor Fitzgerald analyst K. Kluska now forecasts that the company will post earnings per shMay 27, 2025 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Earns "Overweight" Rating from Cantor FitzgeraldCantor Fitzgerald reissued an "overweight" rating and issued a $16.00 price target on shares of Solid Biosciences in a research note on Thursday.May 24, 2025 | marketbeat.comChardan Capital Has Lowered Expectations for Solid Biosciences (NASDAQ:SLDB) Stock PriceChardan Capital decreased their price objective on Solid Biosciences from $16.00 to $15.00 and set a "buy" rating for the company in a research report on Monday.May 21, 2025 | marketbeat.comQ1 Earnings Forecast for SLDB Issued By William BlairSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Analysts at William Blair issued their Q1 2026 earnings per share estimates for shares of Solid Biosciences in a research note issued to investors on Friday, May 16th. William Blair analyst S. Corwin anticipates that the company will earn ($0.5May 21, 2025 | marketbeat.comTruist maintains buy on Solid Biosciences stock, price target at $16May 18, 2025 | investing.comDimensional Fund Advisors LP Purchases 192,714 Shares of Solid Biosciences Inc. (NASDAQ:SLDB)Dimensional Fund Advisors LP lifted its position in Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 270.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 264,069 shares of the company's stock after acquiring an additional 192,714 shMay 18, 2025 | marketbeat.comWhen Might Solid Biosciences Run Out Of Money?May 17, 2025 | finance.yahoo.comSolid Biosciences (NASDAQ:SLDB) Upgraded by Cantor Fitzgerald to "Strong-Buy" RatingCantor Fitzgerald raised Solid Biosciences to a "strong-buy" rating in a research report on Tuesday.May 17, 2025 | marketbeat.comSolid Biosciences Inc.: Solid Biosciences Reports First Quarter 2025 Financial Results and Provides Business UpdatesMay 16, 2025 | finanznachrichten.deSolid Biosciences (SLDB) Expected to Announce Earnings on WednesdaySolid Biosciences (NASDAQ:SLDB) will be releasing its Q1 2025 earnings before the market opens on Wednesday, May 21. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-21-solid-biosciences-inc-stock/)May 16, 2025 | marketbeat.comSolid Biosciences files for $400M mixed securities shelf offeringMay 16, 2025 | msn.comSolid Biosciences Reports First Quarter 2025 Financial Results and Provides Business UpdatesMay 15, 2025 | globenewswire.comSolid Biosciences Inc. (NASDAQ:SLDB) Given Average Rating of "Buy" by BrokeragesSolid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) has been assigned an average recommendation of "Buy" from the twelve brokerages that are covering the firm, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation and four have given a strong buy recoMay 4, 2025 | marketbeat.comSolid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 1, 2025 | globenewswire.comSolid Biosciences to Present Phase 1/2 Trial Data for SGT-003 Gene Therapy at ASGCT 2025 Annual MeetingMay 1, 2025 | nasdaq.comSolid Biosciences to Participate at The Citizens Life Sciences ConferenceApril 30, 2025 | globenewswire.comSolid Biosciences to Present at the American Society of Gene and Cell Therapy’s 28th Annual MeetingApril 29, 2025 | finance.yahoo.comSolid Biosciences to Present at the American Society of Gene and Cell Therapy's 28th Annual MeetingApril 29, 2025 | globenewswire.comResearch Analysts Set Expectations for SLDB Q1 EarningsSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Solid Biosciences in a research report issued to clients and investors on Monday, April 21st. Leerink Partnrs analyst J. Schwartz expects that the company will poApril 26, 2025 | marketbeat.comWalleye Capital LLC Sells 233,270 Shares of Solid Biosciences Inc. (NASDAQ:SLDB)Walleye Capital LLC reduced its holdings in shares of Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 59.5% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 158,831 shares of the company's stock after selling 233,270 shares during the period. Walleye CapApril 25, 2025 | marketbeat.comJPMorgan Chase & Co. Purchases 945,863 Shares of Solid Biosciences Inc. (NASDAQ:SLDB)JPMorgan Chase & Co. raised its position in shares of Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 9,393.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 955,932 shares of the company's stock after puApril 22, 2025 | marketbeat.comTrexquant Investment LP Purchases 139,851 Shares of Solid Biosciences Inc. (NASDAQ:SLDB)Trexquant Investment LP lifted its position in shares of Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 256.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 194,281 shares of the company's stock after purchasingApril 14, 2025 | marketbeat.comSolid Biosciences Inc. (NASDAQ:SLDB) Shares Sold by ADAR1 Capital Management LLCADAR1 Capital Management LLC cut its position in shares of Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 87.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 148,903 shares of the company's stock afteApril 9, 2025 | marketbeat.comSolid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy SpaceApril 8, 2025 | seekingalpha.comCan Solid Biosciences Challenge Sarepta in the DMD Market?Solid Biosciences' Duchenne muscular dystrophy (DMD) drug could provide superior outcomes compared to an already approved medication projected to make billions.April 8, 2025 | marketbeat.comSolid Biosciences Inc. (NASDAQ:SLDB) Receives Average Rating of "Buy" from AnalystsSolid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) has earned an average recommendation of "Buy" from the twelve ratings firms that are currently covering the stock, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a buy recommendation and four have assigneApril 8, 2025 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Trading Down 7.9% - Time to Sell?Solid Biosciences (NASDAQ:SLDB) Stock Price Down 7.9% - Time to Sell?April 6, 2025 | marketbeat.comSolid Biosciences reports inducement grants under Nasdaq listing ruleApril 2, 2025 | markets.businessinsider.comSolid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 1, 2025 | globenewswire.comTruist Financial Keeps Their Buy Rating on Solid Biosciences (SLDB)March 21, 2025 | markets.businessinsider.comSolid Biosciences Inc. (SLDB): Among Top Insider Purchases Last MonthMarch 14, 2025 | insidermonkey.comJPMorgan Chase & Co. Issues Pessimistic Forecast for Solid Biosciences (NASDAQ:SLDB) Stock PriceJPMorgan Chase & Co. lowered their price objective on Solid Biosciences from $12.00 to $11.00 and set an "overweight" rating for the company in a research report on Thursday.March 14, 2025 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Stock Price Up 0.5% - Still a Buy?Solid Biosciences (NASDAQ:SLDB) Trading Up 0.5% - What's Next?March 13, 2025 | marketbeat.comSolid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Rating of "Buy" from BrokeragesShares of Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) have been given an average rating of "Buy" by the thirteen analysts that are covering the stock, MarketBeat.com reports. Nine research analysts have rated the stock with a buy recommendation and four have issued a strong buy recommenMarch 13, 2025 | marketbeat.comSolid Biosciences (SLDB) Receives a Buy from J.P. MorganMarch 12, 2025 | markets.businessinsider.comSolid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific ConferenceMarch 12, 2025 | globenewswire.comEquities Analysts Offer Predictions for SLDB Q1 EarningsSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Research analysts at HC Wainwright lifted their Q1 2025 EPS estimates for shares of Solid Biosciences in a report released on Monday, March 10th. HC Wainwright analyst A. He now expects that the company will post earnings of ($0.43) per share fMarch 12, 2025 | marketbeat.com Get Solid Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter. Email Address SLDB Media Mentions By Week SLDB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLDB News Sentiment▼1.240.88▲Average Medical News Sentiment SLDB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLDB Articles This Week▼94▲SLDB Articles Average Week Get Solid Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Calliditas Therapeutics AB (publ) News Today Amphastar Pharmaceuticals News Today Aurinia Pharmaceuticals News Today Enliven Therapeutics News Today Wave Life Sciences News Today Mineralys Therapeutics News Today Arcus Biosciences News Today CureVac News Today Spyre Therapeutics News Today Phibro Animal Health News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLDB) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solid Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solid Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SLDB Stock Free SLDB Stock Alerts